Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GL.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GL.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GL.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.78NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.78NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.78NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.45NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.34.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.34.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.34.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JD.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.79NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.79NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.79NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HP.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FU.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FU.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used